Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-15

Clinical Trial Update: Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing metronidazole alone to metronidazole plus rifampin for Clostridium difficile–associated diarrhea; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METRONIDAZOLE (Metronidazole)
  • RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: McMaster University | Conditions: Clostridium Enterocolitis, Antibiotic-Associated Diarrhea | Phase 3 | Status: COMPLETED